Core Viewpoint - Infinitus (300582) announced an investment through its wholly-owned subsidiary, Hangzhou Infinitus Equity Investment Co., Ltd., to acquire stakes in Qinghai Spring Blossoms Biotechnology Co., Ltd. and Hangzhou Bincao Biotechnology Co., Ltd. [1] Group 1: Investment Details - The company plans to invest 13.44 million yuan in cash to subscribe for an additional registered capital of 1.344 million yuan in Qinghai Spring Blossoms, with the remaining amount recorded as capital surplus [1] - The company will also acquire all registered capital of 1.56 million yuan from Xu Danhong and Gao Minjian in Hangzhou Bincao Biotechnology Co., Ltd. [1] - After the transactions, the company will directly hold 2.62% of Qinghai Spring Blossoms and indirectly hold 3.04% through Bincao Biotechnology [1] Group 2: Technology and Business Focus - Qinghai Spring Blossoms utilizes biotechnology, plant growth lighting, and environmental control technology to standardize the supply of high-value-added raw materials [1] Group 3: Management Commitment - The company's actual controller and chairman, Guichao Hua, will assume a potential buyback obligation for this investment [1]
英飞特:全资子公司拟增资认购春暖花开股权